About SUTUREGARD® | A Linear Complex Wound Closure Device Company
X

Our Company

Dan Ladizinsky, MD
CEO

Doctor

Dan practiced plastic and reconstructive surgery for 29 years, consulted to the medical technology and biotechnology industries for over 25 years, and founded Oxygenesys, LLC and Galaxea, LLC.  He has helped bring wound healing medical device products to market and had a successful exit when Oxygenesys was acquired. He is a former fellow of the American College of Surgeons and has been board certified in General Surgery, Plastic Surgery and Surgery of the Hand. He is an expert in skin biology and wound healing (multiple publications and grants), and an inventor/author on multiple US patents. As staff surgeon at Kaiser Permanente Northwest, he held the roles of Chief of Plastic Surgery, ASC Chief of Staff and Chief Surgical Officer and was awarded as a Distinguished Physician by his colleagues. 

Jen Akeroyd, PhD
COO & Chair of the Board

Doctor

Before co-inventing the SUTUREGARD® device, Jen published in the fields of skin cancer and wound healing. She has won funding for SUTUREGARD® Medical through grants and pitch competitions (Pitch Oregon seed stage winner). Jen was named Entrepreneur of the Year in 2017 by RAIN Oregon.

Bill Lear, MD
CTO

Doctor

Bill is a board-certified dermatologist and fellowship-trained Mohs surgeon, he has published extensively on the topic of surgical devices and reconstruction in several textbook chapters and in peer-reviewed journals. He is a fellow of the American Academy of Dermatology and of the American College of Mohs Surgeons and is the Program Director of the Samaritan Health Services Micrographic Surgery and Dermatologic Oncology Fellowship Program. 

Ryan Egeland, MD, PhD
Member of the Board

Doctor

Dr. Egeland joined CSI as Vice President of Medical Affairs in November of 2017. He has responsibilities providing global leadership, medical counsel and guidance to the organization on matters related to cardiovascular medicine, product and technology development, medical education, market development, quality assurance, clinical program design, clinical data analysis, regulatory affairs and business development. Prior to joining CSI, Dr. Egeland held roles in marketing, medical affairs and business development at Medtronic. Before this, he trained as a plastic and reconstructive surgeon at Northwestern Memorial Hospital, and received an MD with honors from Harvard Medical School. Dr. Egeland also holds a PhD in biochemistry and engineering from the University of Oxford, where he also completed a MBA as a Rhodes Scholar.

Melvin W. Ellis, MBA
Member of the Board

Doctor

Mel is a seasoned business executive, having over 25 years in business operations and over 10 years as a professional venture capital investor. Most recently, Mel was Interim Operations Manager for IndustrialENET, a fast-growth specialty engineering company in Oregon. IENET tasked Mel with bringing “good business practices” to the firm, including upgrading their accounting, legal, and insurance service providers, implementing an OSHA-compliant safety program and a pre-employment drug-screening process, drafting the first-ever strategic business plan, and recruiting and hiring four young engineers and two support staff members. From 1991-2015, Mel was CEO/Owner of HumphreyLine, Inc., a $10 Million American manufacturing company serving the promotional products industry. Although a small player, HumphreyLine followed a very specific operating strategy and was seen as an industry leader. The Company’s Made-in-America manufacturing focus, combined with its “Serve-the-Customer” operating philosophy, resulted in all-time industry service records, best-in-class product quality, and a solid regulatory compliance record (FDA, OSHA, Consumer Product Safety Improvement Act). In late 2014, HumphreyLine was purchased by a strategic buyer, and for the next year, Mel assisted with the transition to the new ownership. From 1980-1990, Mel was a venture capital investor, first in Boston and later as Founder and Director of Salomon Brothers Venture Capital in New York, specializing in early-stage health care and technology firms. He earned his BA at Stanford and his MBA at Harvard, and served his military duty as Supply Officer onboard USS FARRAGUT (DLG-6).

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now